Loading company…
Seismic Therapeutic uses machine learning and biology tools to develop immunology drugs and antibodies.
Founded in 2020, Seismic Therapeutic combines machine learning, structural biology, protein engineering, and translational immunology for biologics discovery and drug development. Its pipeline targets dysregulated adaptive immunity and autoimmune diseases. The company is based in Cambridge, US, and is at Series B stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in